KR20140035995A - 고순도 및 결정질 다이메틸 푸마레이트의 제조 방법 - Google Patents

고순도 및 결정질 다이메틸 푸마레이트의 제조 방법 Download PDF

Info

Publication number
KR20140035995A
KR20140035995A KR1020147000390A KR20147000390A KR20140035995A KR 20140035995 A KR20140035995 A KR 20140035995A KR 1020147000390 A KR1020147000390 A KR 1020147000390A KR 20147000390 A KR20147000390 A KR 20147000390A KR 20140035995 A KR20140035995 A KR 20140035995A
Authority
KR
South Korea
Prior art keywords
dimethyl
dimethyl fumarate
fumarate
ppm
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147000390A
Other languages
English (en)
Korean (ko)
Inventor
존 구조우스키
윌리엄 키스먼
어윈 얼댐
Original Assignee
바이오겐 아이덱 엠에이 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47296498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140035995(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 바이오겐 아이덱 엠에이 인코포레이티드 filed Critical 바이오겐 아이덱 엠에이 인코포레이티드
Publication of KR20140035995A publication Critical patent/KR20140035995A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/62—Use of additives, e.g. for stabilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/593—Dicarboxylic acid esters having only one carbon-to-carbon double bond
    • C07C69/60—Maleic acid esters; Fumaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/604—Polycarboxylic acid esters, the acid moiety containing more than two carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020147000390A 2011-06-08 2012-06-08 고순도 및 결정질 다이메틸 푸마레이트의 제조 방법 Ceased KR20140035995A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161494775P 2011-06-08 2011-06-08
US61/494,775 2011-06-08
PCT/US2012/041715 WO2012170923A1 (en) 2011-06-08 2012-06-08 Process for preparing high purity and crystalline dimethyl fumarate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157017537A Division KR20150080037A (ko) 2011-06-08 2012-06-08 고순도 및 결정질 다이메틸 푸마레이트의 제조 방법

Publications (1)

Publication Number Publication Date
KR20140035995A true KR20140035995A (ko) 2014-03-24

Family

ID=47296498

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020147000390A Ceased KR20140035995A (ko) 2011-06-08 2012-06-08 고순도 및 결정질 다이메틸 푸마레이트의 제조 방법
KR1020157017537A Withdrawn KR20150080037A (ko) 2011-06-08 2012-06-08 고순도 및 결정질 다이메틸 푸마레이트의 제조 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020157017537A Withdrawn KR20150080037A (ko) 2011-06-08 2012-06-08 고순도 및 결정질 다이메틸 푸마레이트의 제조 방법

Country Status (32)

Country Link
US (1) US9422226B2 (enExample)
EP (1) EP2718257B1 (enExample)
JP (3) JP6385273B6 (enExample)
KR (2) KR20140035995A (enExample)
CN (1) CN103649041A (enExample)
AU (1) AU2012267524A1 (enExample)
BR (1) BR112013031616A2 (enExample)
CA (1) CA2838271A1 (enExample)
CL (1) CL2013003483A1 (enExample)
CO (1) CO6821956A2 (enExample)
CY (1) CY1119920T1 (enExample)
DK (1) DK2718257T3 (enExample)
EA (1) EA201391638A1 (enExample)
EC (1) ECSP14013123A (enExample)
ES (1) ES2659771T3 (enExample)
HR (1) HRP20180203T1 (enExample)
HU (1) HUE036085T2 (enExample)
IL (1) IL229656A0 (enExample)
LT (1) LT2718257T (enExample)
ME (1) ME02960B (enExample)
MX (1) MX355421B (enExample)
NO (1) NO2820009T3 (enExample)
NZ (1) NZ618178A (enExample)
PE (1) PE20141639A1 (enExample)
PH (1) PH12013502498A1 (enExample)
PL (1) PL2718257T3 (enExample)
PT (1) PT2718257T (enExample)
RS (1) RS56972B1 (enExample)
SG (1) SG195227A1 (enExample)
SI (1) SI2718257T1 (enExample)
SM (1) SMT201800098T1 (enExample)
WO (1) WO2012170923A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023241A1 (en) 2003-09-09 2005-03-17 Fumapharm Ag The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
SI2801354T1 (sl) 2004-10-08 2017-07-31 Forward Pharma A/S Farmacevtske sestave z nadzorovanim sproščanjem, ki zajemajo ester fumarne kisline
DK2334378T3 (da) 2008-08-19 2014-07-07 Xenoport Inc Prodrugs af methylhydrogenfumarat, farmaceutiske sammensætninger deraf og fremgangsmåder til anvendelse
JP6385273B6 (ja) 2011-06-08 2023-12-15 バイオジェン・エムエイ・インコーポレイテッド 高純度結晶性ジメチルフマラートの調製方法
JP2015527372A (ja) 2012-08-22 2015-09-17 ゼノポート，インコーポレイティド 副作用を低減させるモノメチルフマレートおよびそのプロドラッグの投与方法
US20140348915A9 (en) 2012-08-22 2014-11-27 Xenoport, Inc. Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
JP6506174B2 (ja) 2012-12-21 2019-04-24 バイオジェン エムエー インコーポレイテッド 重水素置換されたフマル酸誘導体
CN105452213B (zh) 2013-03-14 2017-09-22 阿尔克梅斯制药爱尔兰有限公司 富马酸酯前体药物及其在治疗多种疾病中的应用
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
WO2014160633A1 (en) 2013-03-24 2014-10-02 Xenoport, Inc. Pharmaceutical compositions of dimethyl fumarate
CN104098471A (zh) * 2013-04-03 2014-10-15 南京卡文迪许生物工程技术有限公司 富马酸二甲酯多晶型物及其制备方法和药物组合物
US9302977B2 (en) 2013-06-07 2016-04-05 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
US9840456B2 (en) * 2013-09-25 2017-12-12 Glenmark Pharmaceuticals Limited Process for preparation of dimethyl fumarate
WO2014203231A2 (en) * 2014-01-24 2014-12-24 Shilpa Medicare Limited Process for preparation of dimethyl-(e)-butenedioate
CA2940845C (en) 2014-02-24 2019-09-24 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
EP3110408B1 (en) 2014-02-28 2019-01-16 Banner Life Sciences LLC Controlled release enteric soft capsules of fumarate esters
US10626076B2 (en) * 2014-03-17 2020-04-21 Biophore India Pharmaeuticals Pvt. Ltd. Process for the synthesis of dimethyl fumarate
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2016001093A1 (en) * 2014-07-03 2016-01-07 Synthon B.V. Process for making microcrystalline dimethyl fumarate
CN104151165B (zh) * 2014-08-11 2016-08-24 广东东阳光药业有限公司 制备富马酸二甲酯的方法
CN104761453A (zh) * 2015-04-22 2015-07-08 河南中帅医药科技股份有限公司 一种富马酸二甲酯晶型及其制备方法
US10085961B2 (en) * 2015-06-01 2018-10-02 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of dimethyl fumarate
CA2989581A1 (en) * 2015-06-17 2016-12-22 Biogen Ma Inc. Dimethyl fumarate particles and pharmaceutical compositions thereof
CN106316841A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种富马酸二甲酯的制备方法
WO2017013672A1 (en) * 2015-07-23 2017-01-26 Natco Pharma Ltd Process for the preparation of pharmaceutical grade dimethyl fumarate
US10011663B2 (en) 2016-02-04 2018-07-03 Eastman Chemical Company Vulcanizing composition containing cyclododecasulfur and improved cyclododecasulfur compound
RU2616605C1 (ru) * 2016-04-07 2017-04-18 Олег Ростиславович Михайлов Кристаллическая бета - модификация (Е)-диметилбутендиоата, способ её получения и фармацевтическая композиция на её основе
CN107285320A (zh) * 2017-08-02 2017-10-24 内蒙古新福地科技有限公司 一种氟硅酸钠的结晶方法及装置
FI3694863T3 (fi) 2017-10-10 2023-08-18 Pfizer Lorlatinibin vapaan emäksen hydraatin kidemuoto
WO2021142062A1 (en) 2020-01-10 2021-07-15 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
KR102271575B1 (ko) * 2020-09-16 2021-07-01 김갑용 염의 이온교환법을 이용한 친환경 고효율 에스터화반응 기반의 에스터화합물 제조방법 및 이의 화합물
JP6865489B1 (ja) * 2020-10-20 2021-04-28 株式会社エス・ディー・エス バイオテック ２，３，５，６−テトラクロロ−１，４−ベンゼンジカルボン酸ジメチルの製造方法
CN117550970A (zh) * 2023-10-30 2024-02-13 寿光金远东变性淀粉有限公司 一种高纯度衣康酸二甲酯的生产方法

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1848724A (en) 1932-03-08 Alphons
US2764609A (en) * 1953-07-24 1956-09-25 Monsanto Chemicals Isomerization of dialkyl maleates to dialkyl fumarates
US3078302A (en) * 1958-09-25 1963-02-19 Monsanto Chemicals Production of dialkyl fumarates
US3993684A (en) 1971-08-20 1976-11-23 Western Litho Plate & Supply Co. Monomeric compounds
US4866187A (en) 1976-09-24 1989-09-12 Exxon Research & Engineering Company Thio-bis(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4568756A (en) 1976-09-24 1986-02-04 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4965375A (en) 1976-09-24 1990-10-23 Exxon Research And Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4239636A (en) 1978-10-23 1980-12-16 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US4417062A (en) 1976-09-24 1983-11-22 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US5118835A (en) 1976-09-24 1992-06-02 Exxon Research & Engineering Co. Thio-bis(alkyl lactone acid esters) and thio-bis (Hydrocarbyl diacid esters) are usefull additives for lubricating compositions
JPS60193946U (ja) 1984-03-01 1985-12-24 内山　茂夫 変色炎を有するろうそく
JPS60193946A (ja) * 1984-03-16 1985-10-02 Nippon Oil & Fats Co Ltd ジイソプロピルフマレ−トの製造法
CH664150A5 (de) 1985-01-15 1988-02-15 Peter Paul Prof Dr Speiser Fumarsaeureprodrug, verfahren zu seiner herstellung und dieses enthaltende darreichungsformen.
US5149695A (en) 1985-01-15 1992-09-22 Speiser Peter P Fumaric acid derivatives, process for the production thereof and pharmaceutical compositions containing same
JPS61246147A (ja) * 1985-04-22 1986-11-01 Nippon Shokubai Kagaku Kogyo Co Ltd マレイン酸ジアルキルエステルの精製方法
US4906394A (en) 1986-10-07 1990-03-06 Exxon Chemical Patents Inc. Lactone modified mono-or dicarboxylic acid based adduct dispersant compositions
US4866139A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified, esterified dispersant additives useful in oleaginous compositions
US4954276A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4954277A (en) 1986-10-07 1990-09-04 Exxon Chemical Patents Inc. Lactone modified, esterified or aminated additives useful in oleaginous compositions and compositions containing same
US4866140A (en) 1986-10-07 1989-09-12 Exxon Chemical Patents Inc. Lactone modified adducts or reactants and oleaginous compositions containing same
US4963275A (en) 1986-10-07 1990-10-16 Exxon Chemical Patents Inc. Dispersant additives derived from lactone modified amido-amine adducts
US5032320A (en) 1986-10-07 1991-07-16 Exxon Chemical Patents Inc. Lactone modified mono- or dicarboxylic acid based adduct dispersant compositions
DE3711155A1 (de) 1987-04-02 1988-10-13 Bayer Ag Verfahren zur herstellung von maleinsaeuredimethylester
US4971711A (en) 1987-07-24 1990-11-20 Exxon Chemical Patents, Inc. Lactone-modified, mannich base dispersant additives useful in oleaginous compositions
US4820432A (en) 1987-07-24 1989-04-11 Exxon Chemical Patents Inc. Lactone-modified, Mannich base dispersant additives useful in oleaginous compositions
US4959389A (en) 1987-10-19 1990-09-25 Speiser Peter P Pharmaceutical preparation for the treatment of psoriatic arthritis
US5424332A (en) 1987-10-19 1995-06-13 Speiser; Peter P. Pharmaceutical composition and process for the production thereof
US4943382A (en) 1988-04-06 1990-07-24 Exxon Chemical Patents Inc. Lactone modified dispersant additives useful in oleaginous compositions
US5153352A (en) 1988-10-25 1992-10-06 Bristol-Myers Squibb Company Process for preparation of intermediates of carbocyclic nucleoside analogs
DK0608020T3 (da) 1993-01-21 1997-12-29 Akzo Nobel Nv Lufttørrende vandige polymerdispersioner
CN1103398A (zh) 1993-11-30 1995-06-07 张治明 一种由顺酐生产富马酸二甲酯的工艺方法
WO1996016091A1 (fr) 1994-11-21 1996-05-30 Asahi Kasei Kogyo Kabushiki Kaisha Resine durcissable et composition
JP4240536B2 (ja) 1996-06-24 2009-03-18 サイテク・テクノロジー・コーポレーシヨン 重合性尿素／ウレイド官能性モノマー
US6239189B1 (en) 1997-04-01 2001-05-29 Henkel Corporation Radiation-polymerizable composition and printing inks containing same
DE19721099C2 (de) 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
US6376702B1 (en) 1997-07-11 2002-04-23 Showa Denko K.K. Ether compound, production thereof and curable compositions
US6204410B1 (en) 1997-07-11 2001-03-20 Showa Denko Kabushiki Kaisha Ether compounds and process for producing the same
GB9724004D0 (en) 1997-11-13 1998-10-21 Kvaerner Process Tech Ltd Process
DE19814358C2 (de) 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn
DE19839566C2 (de) 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
DE10084257B4 (de) 1999-12-27 2007-03-29 Asahi Kasei Kabushiki Kaisha Polyoxymethylen-Harzzusammensetzung
DE10000577A1 (de) 2000-01-10 2001-07-26 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten
US20020002306A1 (en) * 2000-02-15 2002-01-03 Yasushi Kadowaki Method for producing fumaric acid esters
JP2001281800A (ja) 2000-03-31 2001-10-10 Konica Corp 熱現像写真感光材料
US6586452B1 (en) 2000-07-14 2003-07-01 Merck & Co., Inc. C1 to C4 side chain modified nodulisporic acid analogs
US20020098451A1 (en) 2000-09-07 2002-07-25 Tadashi Arimoto Photothermographic material
DE10101307A1 (de) 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
AU2002219236B2 (en) 2001-01-12 2006-02-09 Biogen International Gmbh Fumaric acid amides
JP2003160535A (ja) * 2001-11-28 2003-06-03 Nof Corp 不飽和二塩基酸ジエステルの製造方法
WO2003080555A1 (en) 2002-02-28 2003-10-02 Sumitomo Chemical Company, Limited Process for producing chromone compound
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
JP2003315960A (ja) 2002-04-25 2003-11-06 Konica Minolta Holdings Inc 銀塩光熱写真ドライイメージング材料
JP4259815B2 (ja) 2002-06-06 2009-04-30 ダイセル化学工業株式会社 高純度酢酸ブチルの製造方法
WO2005023241A1 (en) 2003-09-09 2005-03-17 Fumapharm Ag The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
JP4163653B2 (ja) 2004-02-27 2008-10-08 株式会社日本触媒 光学部品用硬化性組成物
US7557241B2 (en) 2004-08-30 2009-07-07 Sanyo Chemical Industries, Ltd. Method for producing α,β-unsaturated carboxylic acid ester, α,β-unsaturated carboxylic acid ester, and lubricating oil additive
SI2801354T1 (sl) 2004-10-08 2017-07-31 Forward Pharma A/S Farmacevtske sestave z nadzorovanim sproščanjem, ki zajemajo ester fumarne kisline
TWI279403B (en) 2004-10-20 2007-04-21 Eternal Chemical Co Ltd Cyclobutanetetracarboxylate compound and preparation method thereof
WO2006050730A1 (en) 2004-11-10 2006-05-18 Aditech Pharma Ab Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
CA2585798A1 (en) 2004-12-17 2006-06-17 Metanomics Gmbh Process for the control of production of fine chemicals
CN101147100B (zh) 2005-04-22 2010-09-29 佳能株式会社 磁性调色剂
DE102005022845A1 (de) 2005-05-18 2006-11-23 Fumapharm Ag Thiobernsteinsäurederivate und deren Verwendung
WO2007006307A2 (en) 2005-07-07 2007-01-18 Aditech Pharma Ab Novel salts of fumaric acid monoalkylesters and their pharmaceutical use
KR20080032098A (ko) 2005-08-12 2008-04-14 라이온 가부시키가이샤 나노 평활성과 에칭 내성을 가지는 포토레지스트 폴리머 및레지스트 조성물
WO2007042035A2 (en) 2005-10-07 2007-04-19 Aditech Pharma Ab Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders
US20080299196A1 (en) 2005-10-07 2008-12-04 Aditech Pharma Ab Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
AU2006344611A1 (en) 2006-06-16 2007-12-21 Gumlink A/S Chewing gum comprising a hydrophobic enzyme formulation
DK2653873T3 (da) 2007-02-08 2022-07-25 Biogen Ma Inc Sammensætninger og anvendelser til behandling af multipel sklerose
PT2139467T (pt) 2007-02-08 2016-12-16 Biogen Ma Inc Neuroproteção em doenças desmielinizantes
WO2009045637A2 (en) 2007-08-10 2009-04-09 Genomatica, Inc. Methods for the synthesis of acrylic acid and derivatives from fumaric acid
WO2009055690A1 (en) 2007-10-26 2009-04-30 Purolite International, Ltd. Controlled catalysis
EP2223950B1 (en) 2007-12-12 2018-03-07 Mitsubishi Chemical Corporation Aliphatic polyester resin and method for producing the same
KR101699912B1 (ko) 2009-01-09 2017-01-25 포워드 파마 에이/에스 1종 이상의 푸마르산 에스테르를 침식 매트릭스에 함유하는 제제
EP3466420A1 (en) 2009-04-29 2019-04-10 Biogen MA Inc. Dimethyl fumarate for the treatment of friedreich ataxia
JP5615920B2 (ja) 2009-08-07 2014-10-29 インヴィスタ テクノロジーズ エスアエルエル ジエステルを形成するための水素化およびエステル化
PT2533634E (pt) 2010-02-12 2015-12-28 Biogen Ma Inc Neuroproteção em doenças desmielinizantes
CN102757346A (zh) 2011-04-26 2012-10-31 中国科学院兰州化学物理研究所 一种富马酸二甲酯的制备方法
EP2713724A4 (en) 2011-05-26 2015-03-11 Biogen Idec Inc METHODS OF TREATING MULTIPLE SCLEROSIS AND PRESERVING AND / OR INCREASING MYELINE CONTENT
JP6385273B6 (ja) 2011-06-08 2023-12-15 バイオジェン・エムエイ・インコーポレイテッド 高純度結晶性ジメチルフマラートの調製方法
CN102432464A (zh) 2011-12-14 2012-05-02 费近峰 一种富马酸二甲酯的连续生产工艺
CN113244185A (zh) 2012-02-07 2021-08-13 比奥根玛公司 含有富马酸二甲酯的药物组合物
CN102766050A (zh) 2012-08-10 2012-11-07 太仓市运通化工厂 一种富马酸二甲酯的合成方法
JP6506174B2 (ja) 2012-12-21 2019-04-24 バイオジェン エムエー インコーポレイテッド 重水素置換されたフマル酸誘導体
CN103848739A (zh) 2014-03-20 2014-06-11 徐晓宁 一种高纯度富马酸二甲酯的生产方法

Also Published As

Publication number Publication date
JP6385273B6 (ja) 2023-12-15
US9422226B2 (en) 2016-08-23
IL229656A0 (en) 2014-01-30
JP2018162266A (ja) 2018-10-18
NO2820009T3 (enExample) 2018-06-30
PL2718257T3 (pl) 2018-04-30
LT2718257T (lt) 2018-03-12
PH12013502498A1 (en) 2014-01-20
WO2012170923A1 (en) 2012-12-13
ECSP14013123A (es) 2014-06-30
EP2718257A4 (en) 2015-08-12
BR112013031616A2 (pt) 2016-12-06
HUE036085T2 (hu) 2018-06-28
MX355421B (es) 2018-04-18
PT2718257T (pt) 2018-02-26
JP2014522413A (ja) 2014-09-04
ES2659771T3 (es) 2018-03-19
NZ618178A (en) 2016-03-31
JP6385273B2 (ja) 2018-09-05
CY1119920T1 (el) 2018-06-27
SMT201800098T1 (it) 2018-03-08
SG195227A1 (en) 2013-12-30
US20140200363A1 (en) 2014-07-17
PE20141639A1 (es) 2014-11-08
RS56972B1 (sr) 2018-05-31
CN103649041A (zh) 2014-03-19
HRP20180203T1 (hr) 2018-04-06
DK2718257T3 (en) 2018-02-12
EP2718257B1 (en) 2017-11-15
KR20150080037A (ko) 2015-07-08
JP2016155868A (ja) 2016-09-01
SI2718257T1 (en) 2018-04-30
ME02960B (me) 2018-07-20
EA201391638A1 (ru) 2014-05-30
CO6821956A2 (es) 2013-12-31
EP2718257A1 (en) 2014-04-16
MX2013014320A (es) 2014-01-31
CA2838271A1 (en) 2012-12-13
AU2012267524A1 (en) 2013-12-12
CL2013003483A1 (es) 2014-05-09

Similar Documents

Publication Publication Date Title
JP6385273B6 (ja) 高純度結晶性ジメチルフマラートの調製方法
RU2658015C2 (ru) Ингибитор ассоциированного с функцией лимфоцитов антигена-1 (lfa-1), способы его получения и его полиморф
JP2020125317A (ja) オベチコール酸の調製、使用および固体形態
CN101429198B (zh) 去氢骆驼蓬碱衍生物及其应用
US8471041B2 (en) Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US20140011880A1 (en) Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
EP0307303A1 (fr) [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique
EP2311794B1 (en) Polymorphs of bromfenac sodium and methods for preparing bromfenec sodium polymorphs
WO2024061204A1 (zh) 一种制备2-羟乙基氨基己酸酯类化合物方法及其应用
EP3650444B1 (en) Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof
EP0301936B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
EP1861389A1 (fr) Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique
BE884387A (fr) Composition a base d'acides aryloxyalkylaminobenzoiques, leurs sels et leurs esters
US12391640B2 (en) Process of making a crystalline EDG-2 receptor antagonist
BE779775A (fr) Derives de l'uree, procede pour les preparer et leurs applications
CN115701426A (zh) 一种化合物及其制备方法和用途
EP0208622B1 (fr) Procédé de préparation de dérivés N-méthyles de l'ergoline
EP0211728B1 (fr) Procédé de préparation des dérivés N-méthyles du dihydrolysergate de méthyle ou du méthoxylumilysergate de méthyle
JP2002037761A (ja) α−ヒドロキシカルボン酸化合物の製造法
CN118354999A (zh) 一种哒嗪-1(6h)-6-氧代类化合物及其制备方法与应用
CN116462635A (zh) 一种吡嗪-1(2h)-2-氧代类化合物及其制备方法与应用
EP0321349A1 (fr) Procédé de préparation de la N-(chloro-2 benzyl) (thiényl-2)-2 éthylamine
HK40033444A (en) Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of a selective acc inhibitor
CN113004202A (zh) 一种高纯度托伐普坦的制备方法
WO2021138561A1 (en) Novel tetrahydrocurcumin compositions, methods of making, and methods of using the same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140107

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140916

Comment text: Request for Examination of Application

A302 Request for accelerated examination
PA0302 Request for accelerated examination

Patent event date: 20140917

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

AMND Amendment
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141230

Patent event code: PE09021S01D

AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150630

PE0601 Decision on rejection of patent

Patent event date: 20150831

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20141230

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20150831

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20150630

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20141103

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20140916

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151221

Patent event code: PE09021S01D

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20160630

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20151221

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20151201

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20150831

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20150630

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20141230

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20141103

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20140916